Gösta Gahrton
#147,842
Most Influential Person Now
Gösta Gahrton's AcademicInfluence.com Rankings
Gösta Gahrtonphilosophy Degrees
Philosophy
#8031
World Rank
#11335
Historical Rank
Logic
#5068
World Rank
#6428
Historical Rank
Download Badge
Philosophy
Why Is Gösta Gahrton Influential?
(Suggest an Edit or Addition)Gösta Gahrton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group (2003) (2143)
- International uniform response criteria for multiple myeloma (2006) (2014)
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION (1998) (1579)
- Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. (1990) (638)
- International uniform response criteria for multiple myeloma (2006) (519)
- Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. (2003) (445)
- Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres (2001) (337)
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (1998) (299)
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation. (2011) (295)
- Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. (1995) (285)
- HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic Leukemia (1996) (247)
- Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. (2005) (235)
- Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia (1997) (207)
- Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia (2012) (198)
- Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. (1997) (197)
- Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group (2016) (189)
- Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. (1980) (189)
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. (2008) (186)
- Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. (2003) (185)
- Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. (2007) (178)
- Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis. (1970) (176)
- HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA (1985) (175)
- Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. (1986) (175)
- Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study. (2013) (171)
- Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up. (2011) (171)
- International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma. (2010) (161)
- Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia (1984) (159)
- Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (1997) (156)
- Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. (1990) (153)
- Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. (1989) (152)
- Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. (1984) (151)
- Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. (1993) (150)
- CYTOMEGALOVIRUS INFECTION ASSOCIATED WITH AND PRECEDING CHRONIC GRAFT‐VERSUS‐HOST DISEASE (1984) (142)
- Hypersensitive reactions and antibody formation during L‐asparaginase treatment of children and adults with acute leukemia (1976) (137)
- Approach to the treatment of multiple myeloma: a clash of philosophies. (2011) (135)
- American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multip (2015) (134)
- Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. (1990) (131)
- Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). (1996) (130)
- Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. (1990) (123)
- Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. (1994) (119)
- 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. (1998) (119)
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor. (2010) (114)
- Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. (1986) (113)
- Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. (1993) (112)
- Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients. (1991) (107)
- Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. (1983) (103)
- Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. (1994) (103)
- Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. (1998) (103)
- Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation. (1991) (98)
- A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies. (1986) (96)
- Prognostic information from cytogenetic analysis in chronic B- lymphocytic leukemia and leukemic immunocytoma (1985) (95)
- Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. (1994) (94)
- Graft-versus-myeloma effect (1996) (93)
- Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. (1985) (90)
- Extra chromosome 12 and prognosis in chronic lymphocytic leukaemia. (2009) (90)
- Syngeneic transplantation in multiple myeloma – a case-matched comparison with autologous and allogeneic transplantation (1999) (84)
- Primary plasma cell leukemia and autologous stem cell transplantation (2010) (83)
- A predictive model for the clinical response to low dose ara‐C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia (1992) (80)
- Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantation (1993) (79)
- Consistency of chromosomal aberrations in chronic B‐lymphocytic leukemia. A longitudinal cytogenetic study of 41 patients (1988) (78)
- EXTRA CHROMOSOME 12 IN CHRONIC LYMPHOCYTIC LEUKÆMIA (1980) (77)
- Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. (1995) (76)
- Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders (1982) (76)
- Chromosomal aberrations in chronic B-cell lymphocytic leukemia. (1982) (74)
- Retinoblastoma gene deletions in b‐cell chronic lymphocytic leukemia (1992) (73)
- The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants (2005) (72)
- Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma (2019) (71)
- Bone marrow transplantation in multiple myeloma. (1991) (71)
- Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. (1984) (70)
- Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection (1986) (69)
- Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. (1985) (69)
- B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. (1978) (68)
- Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden (1993) (68)
- Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. (1989) (67)
- Stimulation of human myelopoiesis by leukotriene B4. (1985) (67)
- Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. (1984) (64)
- Suicide gene therapy for plasma cell tumors. (1996) (62)
- Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation. (1987) (61)
- Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. (2005) (59)
- Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. (1982) (58)
- Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy. (1991) (58)
- Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage. (2009) (57)
- 5 Cytogenetics in CLL and related disorders (1993) (57)
- Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV‐I) following allogeneic bone marrow transplantation for HTLV‐I positive adult T‐cell leukaemia (1994) (55)
- Efficacy and outcome of autologous transplantation in rare myelomas (2009) (54)
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation (2010) (53)
- Amplification of multiple regions of chromosome 12, including 12q13–15, in chronic lymphocytic leukaemia (1997) (53)
- Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. (2004) (52)
- Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. (2007) (52)
- Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. (2007) (52)
- Identification of progression markers in B-CLL by gene expression profiling. (2005) (51)
- Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients. (1980) (50)
- Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. (2012) (50)
- Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party (2016) (50)
- Trisomy 8 in acute myeloblastic leukemia and sideroachrestic anemia. (1974) (50)
- Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic Leukemia (1989) (50)
- VARIABLES PREDICTING BACTERIAL AND FUNGAL INFECTIONS AFTER ALLOGENEIC MARROW ENGRAFTMENT (1987) (50)
- FOSCARNET FOR CYTOMEGALOVIRUS INFECTIONS (1985) (49)
- Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. (1983) (49)
- The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment (2014) (49)
- Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes (1988) (49)
- DUPLICATION OF PART OF CHROMOSOME NO. 1 IN MYELOPROLIFERATIVE DISEASES (1978) (48)
- Progress in haematopoietic stem cell transplantation for multiple myeloma (2000) (48)
- DNA, RNA and hemoglobin during erythroblast maturation. A cytophotometric study. (1970) (47)
- Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation. (2006) (47)
- EXPERIENCE WITH A COOPERATIVE BONE MARROW TRANSPLANTATION PROGRAM IN STOCKHOLM (1982) (47)
- SUCCESSFUL TREATMENT OF PURE RED-CELL APLASIA WITH CYCLOSPORIN (1984) (46)
- Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population (2014) (46)
- Multiple Myeloma and Related Disorders (2004) (45)
- Molecular analyses of chromosome 12 in chronic lymphocytic leukemia. (1989) (45)
- High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS) (1988) (44)
- Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden. (1993) (43)
- Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia. (1980) (43)
- Mitogenic stimulation of leukemia cells by Epstein-Barr virus. (1979) (43)
- Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS (1989) (43)
- Clinical impact of chromosomal aberrations in multiple myeloma (2011) (43)
- Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation (2013) (42)
- Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting (2001) (42)
- Increased risk of developing acute leukemia after employment as a painter (1987) (41)
- Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation. (2007) (41)
- Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X. (1987) (40)
- A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group. (1989) (40)
- Cytogenetics in CLL and related disorders. (1993) (40)
- Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations (2021) (39)
- Erratum: International uniform response criteria for multiple myeloma (Leukemia (2006) vol. 20 (1467-1473) 10.1038/sj.leu.2404284) (2006) (37)
- Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. (1983) (36)
- Proteasome inhibitors and IMiDs can overcome some high‐risk cytogenetics in multiple myeloma but not gain 1q21 (2016) (36)
- No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease (2003) (36)
- LYMPHOCYTE RESPONSES AFTER CYTOMEGALOVIRUS INFECTION IN BONE MARROW TRANSPLANT RECIPIENTS—A ONE‐YEAR FOLLOW‐UP (1985) (36)
- Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). (1994) (35)
- Significance of the low-density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells. (1984) (35)
- Acute leukemia in professional drivers exposed to gasoline and diesel (1991) (35)
- Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA‐typing (1993) (34)
- Clonal origin of the Philadelphia chromosome from either the paternal or the maternal chromosome number 22. (1974) (34)
- Bone marrow transplantation in three patients with multiple myeloma. (2009) (34)
- Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse. (1988) (33)
- Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma (2007) (33)
- Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT (2015) (33)
- Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage (2021) (32)
- Duplication of part of the long arm of chromosome 1 in myelofibrosis terminating in acute myeloblastic leukemia. (2009) (30)
- International uniform response criteria for multiple myeloma (2007) (30)
- TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy. (2010) (29)
- Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemia. (1985) (29)
- High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. (2007) (29)
- A new variant translocation (19q+, 22q−) in chronic myelocytic leukemia (1974) (28)
- Retroviral‐mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice (1995) (28)
- Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma. (1983) (27)
- MICROSPECTROPHOTOMETRIC QUANTITATION OF THE PERIODIC ACID-SCHIFF (PAS) REACTION IN HUMAN NEUTROPHIL LEUKOCYTES BASED ON A MODEL SYSTEM OF GLYCOGEN MICRODROPLETS. (1964) (27)
- Prognostic value of B‐cell mitogen‐induced and spontaneous thymidine uptake in vitro in chronic B‐lymphocytic leukaemia cells (1985) (26)
- Inhibitors of the bone‐marrow colony formation in sera of patients with leukemia (1972) (26)
- Intensive treatment in order to minimize the ph‐positive clone in chronic myelogenic leukemia (1993) (25)
- Bcl‐2 rearrangements with breakpoints in both vcr and mbr in non‐Hodgkin’s lymphomas and chronic lymphocytic leukaemia (1996) (25)
- Monosomy 7 in two adult patients with acute myeloblastic leukaemia. (2009) (25)
- Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. (1998) (25)
- Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. (1984) (24)
- Mitogen‐Induced Switching of Immunoglobulin Heavy‐Chain Class Secretion in Chronic B‐Lymphocytic Leukaemia and Immunocytoma Cell Populations (1983) (24)
- Indications for haemopoietic precursor cell transplants in Europe (1996) (24)
- Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up (2005) (24)
- Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation (2020) (24)
- Role of chromosomal abnormalities in chronic lymphocytic leukemia. (1987) (24)
- 2 translocations, t(11;14) and t(1;6), in a patient with plasma cell leukaemia and 2 populations of plasma cells. (2009) (24)
- Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation. (1990) (23)
- Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia. (2004) (23)
- Cytochemical population analyses of the DNA, RNA and protein content of human leukemic cells. (2009) (23)
- The prognostic significance of 8p21 deletion in multiple myeloma (2008) (23)
- Treatment of multiple myeloma with interferon alpha: the Scandinavian experience (1991) (23)
- Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT. (2009) (23)
- Mitoxantrone, etoposide and ara‐C vs doxorubicin‐DNA, ara‐C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison (1995) (23)
- A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. (1991) (22)
- Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cells. (1988) (21)
- ALLOGENEIC BONE MARROW TRANSPLANTATION IN MULTIPLE MYELOMA (1996) (21)
- Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia. (1993) (21)
- Leukemia-like pattern of the DNA, RNA, and protein content of individual mononuclear cells in the peripheral blood of patients with infectious mononucleosis. (1969) (20)
- Induction of remission with l‐asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia (1974) (20)
- Quantitative cytochemistry of glycogen in blood cells. Methods and clinical application. (1976) (20)
- Autologous stem-cell transplantation in multiple myeloma. (1995) (20)
- Suicide gene therapy: possible applications in haematopoietic disorders (2001) (20)
- No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study. (1992) (20)
- The content of total and acid-soluble glycogen in the white blood cells and its relation to the staining with the periodic acid-Schiff reagents. (2009) (20)
- Characterization of a hairy cell leukemia‐associated 5q13.3 inversion breakpoint (1997) (19)
- Progress in hematopoietic stem cell transplantation in multiple myeloma (2005) (19)
- Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. (1996) (19)
- Prognostic value of colony-stimulating and colony-forming cells in peripheral blood in acute non-lymphoblastic leukemia. (2009) (19)
- Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia (1996) (18)
- Acute Graft-Versus-Host Disease: Grade and Outcome in Patients With Chronic Myelogenous Leukemia (2000) (18)
- Long‐term follow‐up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy (2002) (18)
- Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma (2007) (18)
- Clinical evaluation of NCA in patients with chronic myelocytic leukemia (1982) (17)
- Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cells. (1994) (17)
- Stem cell transplantation from identical twins in patients with myelodysplastic syndromes (2005) (17)
- Quantitation of the cytosolic glucocorticoid receptor in human normal and neoplastic leukocytes using isoelectric focusing in polyacrylamide gel. (1981) (17)
- Allogeneic bone marrow transplantation in multiple myeloma. (1996) (17)
- Erratum: Myeloma management guidelines: A consensus report from the scientific advisors of the international myeloma foundation (The Hematology Journal (2003) vol, 4 (379-398) 10.1038/sj.thj.6200312) (2004) (17)
- Cytochemical population analyses of continuous cultures of human lymphoblasts derived from acute lymphoblastic leukemia. (1966) (17)
- Colony-forming and colony-stimulating cells in normal human peripheral blood. (1973) (17)
- Isochromosome 17 in a patient with a myeloproliferative disorders terminating in eosinophilic leukemia. (2009) (17)
- Case Report: Treatment of light‐chain amyloidosis with daratumumab monotherapy in two patients (2018) (16)
- Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the ebmt registry (1988) (16)
- Bone marrow transplantation in children (1989) (16)
- Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience (2000) (16)
- Del(3)(p13) in B-prolymphocytic leukemia--a new nonrandom chromosomal aberration possibly related to the c-ras oncogene. (1985) (16)
- Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration? (2019) (16)
- Allogeneic bone marrow transplantation in leukemia. (1988) (16)
- Origin of the Philadelphia chromosome. Tracing of chromosome 22 to parents of patients with chronic myelocytic leukemia. (1973) (15)
- L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. (2009) (15)
- The World Marrow Donor Association (WMDA): its goals and activities (2003) (15)
- Chromosomal aberrations in progressive and indolent chronic B-lymphocytic leukaemia. A longitudinal study. (1988) (15)
- A new translocation involving three chromosomes in chronic myelocytic leukemia, 46,XY,t(9;11;22). (1977) (15)
- Bone marrow transplantation in Europe: major geographical differences (1993) (14)
- Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma (2015) (14)
- Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation. (1986) (14)
- Colony-forming and colony-stimulating cells in relation to prognosis in leukemia. (2009) (14)
- Structural changes in the deoxyribonucleoprotein (DNP) complex of leukocytes from patients with infectious mononucleosis. (1970) (13)
- Clinical significance of mitogen-induced responses in lymphocytes from patients with chronic lymphocytic leukemia. (2009) (13)
- Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and α-interferon on bone marrow cells from patients with myelodysplastic syndromes (1989) (13)
- Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT (2011) (13)
- Progress in allogeneic transplantation for multiple myeloma (2010) (12)
- Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells (2004) (12)
- Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia (2000) (12)
- Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place? (2020) (12)
- An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors (1995) (12)
- Proliferative Activity and Glycogen Accumulation of Erythroblasts in β‐Thalassaemia (1973) (12)
- Successful treatment with prednisone and graft-versus-host disease in an allogeneic bone-marrow transplant recipient. (2009) (12)
- Low-dose ara-C in myelodysplastic syndromes (MDS) and acute leukemia following MDS: proposal for a predictive model. (1994) (11)
- Determination of the glycogen content in single neutrophil leukocytes using a micromodel of leukocyte glycogen. (1975) (11)
- New therapeutic targets in multiple myeloma (2004) (11)
- Allogeneic bone marrow transplantation in patients with multiple myeloma (1989) (11)
- Ox Erythrocyte Cytotoxicity by Phorbol Myristate Acetate‐Activated Human Neutrophils (1983) (11)
- Quantification of α‐Chain Excess in Erythrocytes in β‐Thalassaemia by Microinterferometry * (1972) (11)
- Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma (2022) (11)
- Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation. (2009) (11)
- NORMAL HUMAN NEUTROPHIL LEUKOCYTES AS A REFERENCE SYSTEM FOR THE MICROSPECTROPHOTOMETRICALLY QUANTITATED PERIODIC ACID-SCHIFF REACTION (1966) (11)
- Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction. (1983) (11)
- Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma (2019) (10)
- Microspectrofluorometry of a periodic acid-schiff reaction in blood cells. (1969) (10)
- The periodic acid-Schiff reaction in neutrophil leukocytes in untreated and myleran-treated chronic myelocytic leukemia. A quantitative microspectrophotometric study. (1966) (10)
- Ph chromosome and B-cell malignancy-associated chromosomal aberrations in non-leukaemic immunoblastic B-cell lymphoma. (1985) (10)
- A quantitative cytochemical investigations of DNA, RNA and protein in lymphoid cells from normal, preleukemic and leukemic mice. (1966) (10)
- Etoposide, doxorubicin, cyclophosphamide and high‐dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma (1993) (10)
- ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemia. (1987) (10)
- Allogeneic transplantation in multiple myeloma (2008) (10)
- Induction treatment with α‐interferon in multiple myeloma: An interim report from MGCS (1989) (9)
- CCNU toxicity after an overdose in a patient with Hodgkin's disease. Effects on colony-forming cells (CFU-C) and colony-stimulating activity (CSA). (2009) (9)
- Bone marrow transplantation for acute myeloid leukemia : the EBMT experience. A prospective analysis from HLA-typing (1992) (9)
- Epstein‐barr and other herpes virus antibodies in children with acute leukemia (1971) (9)
- Anthracycline-DNA Complexes as Slow-Release Preparations in the Treatment of Acute Leukemia (1981) (9)
- Low density lipoprotein receptor activity in human leukemic cells--relation to chromosome aberrations. (2009) (9)
- High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS). (1988) (9)
- T‐cell receptor β gene rearrangements in leukaemic B‐cells from patients with chronic lymphocytic leukaemia: association with chromosome 6 deletions (1994) (9)
- Clinical implications of CLL cell proliferation in vitro. (1988) (9)
- No evidence of trisomy 12 or t(11;14) by molecular genetic techniques in chronic lymphocytic leukemia cells with a normal karyotype. (1990) (9)
- [Bone marrow transplantation--an alternative treatment for aplastic anemia and leukemia]. (1977) (9)
- Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting) (2016) (9)
- SERUM VITAMIN B12 DETERMINATIONS AND CYTOCHEMICAL REACTIONS IN THE DIFFERENTIAL DIAGNOSIS OF ACUTE LEUKAEMIA. (2009) (9)
- Chromosome abnormalities and RB1 gene deletions in chronic lymphocytic leukemia. (1993) (9)
- Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation (2010) (8)
- Cytochemical variants of neutrophil leukocyte populations in chronic myelocytic leukaemia. A microspectrophotometric study of the change in the periodic acid-Schiff (PAS) reaction in blood and bone marrow neutrophils during busulfan treatment. (2009) (8)
- NCA: A DIFFERENTIATION ANTIGEN OF MYELOPOIETIC CELLS IN HUMANS AND HOMINOID MONKEYS (1983) (8)
- Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patients (1997) (8)
- Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma (2015) (8)
- Proximal promoter of the murine syndecan‐1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells (2001) (8)
- Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT (2020) (8)
- Influence of interferon-alpha on the expression of cellular oncogenes in primary chronic lymphocytic leukemia cells. (1988) (8)
- Immune phenotype and prognosis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma. (2009) (8)
- Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia (2004) (8)
- Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group. (1994) (7)
- Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival. (2004) (7)
- Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report (2004) (7)
- Goals and activities of the WMDA (2002) (7)
- Adjuvant immunotherapy in acute nonlymphocytic leukemia (1978) (7)
- Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments. (2001) (7)
- Graft‐versus‐leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft‐versus‐host disease in allograft recipients with AML (1987) (7)
- Opinion paper on the current status of the regulation of gene therapy in Europe. (2002) (7)
- Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: update of a prospective randomized study. (1993) (6)
- A new variant translocation (19q plus, 22q minus) in chronic myelocytic leukemia. (1974) (6)
- Are autologous stem cell transplants still required to treat myeloma in the era of novel therapies? A review from the Chronic Malignancies Working Party of the EBMT. (2020) (6)
- Production of a motility factor by a newly established lung adenocarcinoma cell line. (1998) (6)
- Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate. (1988) (6)
- Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia. (1982) (6)
- Cytochemical investigations and serum vitamin B12 determinations in a case of erythroleukaemia. (2009) (6)
- Hepatitis C infection in allogeneic bone marrow transplant recipients (1991) (6)
- Chromosomal satellites as markers in human bone-marrow transplantation. (2009) (6)
- Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma – a retrospective population based study of 1162 patients (2014) (6)
- Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study (2016) (6)
- The importance of patient selection in nonmyeloablative stem cell transplant (NMSCT) for acute and chronic leukaemia, myelodysplastic syndrome, and myeloma (2000) (6)
- Poor age‐corrected survival of chronic lymphocytic leukaemia patients with trisomy 12 (1987) (5)
- Autologous stem cell transplantation (ASCT) vs ASCT followed by reduced-intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: preliminary analysis of a prospective controlled trial by the EBMT (2008) (5)
- Relevance of an academic GMP Pan-European vector infra-structure (PEVI). (2010) (5)
- Treatment options for relapse after autograft in multiple myeloma – report from an EBMT educational meeting (2017) (5)
- Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three cases. (1981) (5)
- Intranuclear hemoglobin in erythroblasts of β-thalassemia. (1974) (5)
- In vitro colony studies in 87 patients with acute nonlymphoblastic leukemia. Prognostic value of colony-stimulating activity and colony-forming cells. (2009) (5)
- Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. (2015) (5)
- Constitutional chromosomal aberration, t(4;12) (q23;p11), in a patient with Ph1 positive chronic myelocytic leukemia. (2009) (5)
- Simultaneously presenting aplastic anaemia and Hodgkin's disease successfully treated with allogeneic bone marrow transplantation (1991) (5)
- Activation of malignant B-lymphocytes: pathophysiologic and clinical importance. (2009) (5)
- Gene marking and gene therapy in multiple myeloma. (1998) (5)
- Goals and activities of the WMDA. World Marrow Donor Association. (2002) (4)
- Clinical findings and prognostic factors in chronic myeloid leukemias. (2009) (4)
- Influence of cell density on the acridine orange binding to deoxyribonucleoprotein complex in leucocytes from patients with infectious mononucleosis and acute leukaemia. (1972) (4)
- Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase (2006) (4)
- Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden. (1990) (4)
- Role of stem cell transplantation in myeloma (2005) (4)
- Cytochemical population analysis of cell linesderived from Burkitt's lymphoma, infectious mononucleosis, and acute lymphoblastic leukemia. (1971) (4)
- Third International Congress of Histochemistry and Cytochemistry (1968) (4)
- Allogeneic transplantation in multiple myeloma (2014) (4)
- The periodic acid-schiff reaction in neutrophil leukocytes-influence of fixation and amylase digestion (2004) (4)
- Treatment of multiple myeloma (1999) (4)
- Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies. (1988) (4)
- EGG Changes in Pectus Excavatum (Funnel Chest) (2009) (4)
- Editorial: The Philadelphia chromosome and chronic myelocytic leukemia (CML) --still a complex relationship? (2009) (4)
- Constitutional inv(3) in myelodysplastic syndromes. (2010) (4)
- Clonal analysis of the response of HL‐60 cells to retinoic acid and vitamin D in the presence or absence of leukocyte‐conditioned medium (1988) (4)
- Trisomy 8 in the chronic phase of Philadelphia negative chronic myelocytic leukaemia. (2009) (4)
- Allogeneic bone marrow transplantation in children at Huddinge Hospital. (1988) (4)
- Specific chromosomal markers in B- and T-cell chronic lymphocytic leukemia. (1985) (4)
- Acute myelogenous leukemia of unfavourable prognosis treated with retinoic acid, vitamin D3, alpha-interferon and low doses of cytosine arabinoside. (1986) (3)
- Glycogen synthesis in normal, leukemic and polycythemic leukocytes. Preliminary report of a quantitative cytochemical study. (2009) (3)
- Bone marrow transplantation for aplastic anemia and acute leukemia at Huddinge Hospital. (1981) (3)
- Incidence of specific chromosomal aberrations in chronic lymphocytic leukemia. (1981) (3)
- Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution and Outcomes over More Than Two Decades within EBMT Centers (2014) (3)
- In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al (2013) (3)
- DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML). (1992) (3)
- ECG changes in pectus excavatum (funnel chest). A pre- and postoperative study. (1961) (3)
- Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and alpha-interferon on bone marrow cells from patients with myelodysplastic syndromes. (1989) (3)
- Phase II trial of allogeneic transplantation plus novel drugs in multiple myeloma: effect of intensifying reduced intensity conditioning with bortezomib and adding maintenance treatment. (2022) (3)
- Prognostic implications of in vitro colony studies and clonal chromosomal aberrations in adults with acute leukaemia. (2009) (3)
- Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival. (1990) (2)
- Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study. (1991) (2)
- Cancer research in the European community--report from a meeting in Stockholm in 1995. (1996) (2)
- A Comparison of Two Different Reduced Intensity Conditioning (RIC) Allograft Strategies In Patients with Multiple Myeloma, An EBMT Analysis (2010) (2)
- Chromosome 13q14 deletions in lymphoid malignancies (1996) (2)
- Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia (2004) (2)
- Genetically Modified Autoactivated Cells Expressing Intracellular Forms of GM‐CSF as a Model for Regulated Administration of Cytokines (2005) (2)
- [Randomization and ethics. Patient participation is a serious demand in medical research]. (1992) (2)
- Bone marrow and peripheral blood stem cell transplantation in multiple myeloma. (1997) (2)
- Treosulfan Plus Fludarabine – Encouraging Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma (2016) (2)
- Lymphomas 6 q Deletions in Acute Lymphoblastic Leukemia and Non-Hodgkin ' s (1998) (2)
- Predictive Factors for Chronic Graft-versus-Host Disease and Leukemic Relapse After Allogeneic Bone Marrow Transplantation (1988) (2)
- Allogeneic bone marrow transplantation in haematological malignancies. Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). (1989) (2)
- Allogeneic transplantation in multiple myeloma. (2011) (2)
- Multiple myeloma — a curable disease? (1992) (2)
- Cytochemical Population Analyses of Glycogen in Neutrophil Leukocytes of Chronic Myelocytic Leukaemia during Busulfan Treatment (1972) (2)
- [Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life]. (1991) (2)
- Pathogenetic and clinical significance of chromosomal aberrations in B-cell chronic lymphocytic leukemia (1985) (2)
- Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study. (2004) (2)
- Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsiveness. (2009) (2)
- [High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support]. (1995) (2)
- Historical note on the discovery of the Philadelphia chromosome. (2012) (2)
- Bone marrow transplantation with unrelated volunteer donors. (1991) (2)
- Pro: allogeneic transplantation in multiple myeloma. (2006) (1)
- Lymphocyte Reactivity After Cytomegalovirus Infection May Predict Development of Chronic Graft Versus Host Disease (1985) (1)
- Factors Associated with Infections After Bone-Marrow Transplantation (1985) (1)
- Peripheral blood or bone marrow cells myeloablative conditioning allogeneic transplantation for multiple myeloma (2007) (1)
- A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells (2016) (1)
- Transport and Storage of Anthracyclines in Experimental Systems and Human Leukemia (1982) (1)
- Allogeneic transplantation and treatment with donor lymphocytes (2004) (1)
- A quantified periodic acid-Schiff reaction in normal and leukemic leukocytes. (1965) (1)
- ACUTE MYELOGENOUS LEUKEMIA OF UNFAVOURABLE PROGNOSIS TREATED WITH RETINOIC ACID, VITAMIN D3, ALPHA‐INTERFERON AND LOW DOSES OF CYTOSINE ARA‐BINOSIDE (2009) (1)
- High-dose treatment of multiple myeloma. (1999) (1)
- Allogeneic transplantation in multiple myeloma – How, when or at all? (2015) (1)
- [What is the treatment for acute leukemia and aplastic anemia?]. (1984) (1)
- Oligoclonal reconstitution after high dose therapy with PBPCT in myeloma patients: Implications for assessment of remission status (2001) (1)
- Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care (2022) (1)
- Bone marrow transplantation in Europe: major geographical differences. The European Group for Bone Marrow Transplantation [EBMT]. (1993) (1)
- The Periodic Acid-Schiff Reaction in Neutrophil Leukocytes in Chronic Myeloproliferative Diseases A microspectrophotometric study (2009) (1)
- Myeloid Cells and Serum of Leukemic Patients Nonspecific Cross-reacting Antigen in Normal and Leukemic (2013) (0)
- [The Nobel Prize. This year's prize-winners are rewarded for clinical methods]. (1990) (0)
- Donor and recipient origin of herpesvirus-reactive lymphocytes after bone marrow transplantation (2005) (0)
- The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia (2008) (0)
- Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis, (2011) (0)
- Introduction (2001) (0)
- the Maternal Chromosome Number 22 Clonal Origin of the Philadelphia Chromosome From Either the Paternal or (2011) (0)
- stages II and III: a randomized study from the Myeloma Group of versus melphalan/prednisone in the treatment of multiple myeloma Natural interferon-alpha in combination with melphalan/prednisone (2013) (0)
- Induction treatment with alpha-interferon in multiple myeloma: an interim report from MGCS. (1989) (0)
- [Bone marrow transplantation]. (1978) (0)
- [Multiple myeloma--pathophysiology and treatment]. (1988) (0)
- [Bone marrow transplantation--rapid development towards new indications]. (1988) (0)
- [The gray area between research and trials should be better explained]. (2017) (0)
- [Bone marrow transplantation at Huddinge Hospital: More and more successful therapy in malignant disease--the indications are gradually increasing]. (1985) (0)
- [Bone marrow transplantation--rapid development toward new indications]. (1988) (0)
- with Infectious Mononucleosis Patients Individual Mononuclear Cells in the Peripheral Blood of Leukemia-like Pattern of the DNA, RNA, and Protein Content of (2013) (0)
- [Palliative care. Allow active euthanasia when there is no hope of cure]. (2011) (0)
- Selective Decontamination of Alimentary Tract Microbial Flora in Patients Treated with Bone Marrow Transplantation: A Microbiological Study (1984) (0)
- European Cooperative Group for Bone Marrow Transplantation Bone marrow transplantation in multiple myeloma: report from the (2011) (0)
- THE FABRIC OF LIFE: MICROSCOPY IN THE SEVENTEENTH CENTURY (1997) (0)
- Allogeneic Transplantation and Cell Therapy in Multiple Myeloma (2016) (0)
- monocytic differentiation Elevated low density lipoprotein receptor activity in leukemic cells with (2011) (0)
- Leukemia-like Pattern of the DNA , RNA , and Protein Content of Individual Mononuclear Cells in the Peripheral Blood of Patients with Infectious 1 @ 2 (2006) (0)
- autologous stem cell transplantation treatment of multiple myeloma patients who are candidates for International Myeloma Working Group consensus approach to the (2012) (0)
- Book Review Essentials of Stem Cell Biology Edited by Robert Lanza, John Gearhart, Brigid Hogan, and others. 548 pp., illustrated. San Diego, Calif., Elsevier Academic Press, 2006. $129.95. 0-12-088442-9 (2006) (0)
- NonspecificCross-reacting Antigenin Normaland LeukemicMyeloid Cellsand Serumof LeukemicPatients' (1980) (0)
- [New facts about bone marrow transplantation. An unrelated donor is as good as a related one]. (1994) (0)
- [Cervix-dilating drugs in obstetrical practice]. (1958) (0)
- treosulfan plus : ab62 fl: ab62 udarabine : ab62 - : ab62 encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma : ab62 (2016) (0)
- Syngeneic transplants Stem cell transplantation from identical twins in patients with myelodysplastic syndromes (2005) (0)
- Bone marrow transplantation in multiple melanoma. (1986) (0)
- Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups (2021) (0)
- Origin of the Philadelphia chromosome. Tracing of chromosome 22 to parents of patients with chronic myelocytic leukemia. (1973) (0)
- [A common therapy program of leukemia for several hospitals]. (1970) (0)
- A063 Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial (2009) (0)
- Immunobiology of Bone Marrow Transplantation (2009) (0)
- [Chronic myeloid leukemia--attempts at finding new methods of treatment]. (1975) (0)
- Allogeneic stem cell transplantation for multiple myeloma. (1997) (0)
- I04 Stem cell transplantation in multiple myeloma (2007) (0)
- Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma. (2017) (0)
- Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma – Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation (2019) (0)
- Chapter 80. Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma (2007) (0)
- Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation (1980) (0)
- Translocation between chromosome 7 and chromosome 22, t(7;22)(p22;q12), in a patient with chronic myelocytic leukemia (1979) (0)
- Significance of allogeneic transplantation in Multiple Myeloma (2009) (0)
- Frequency of Reactivation of Varicella-Zoster Virus (VZV) Infection with and without Symptoms After Bone Marrow Transplantation (1985) (0)
- Professor Lars Erik Böttiger, in memoriam (1924–2009) (2009) (0)
- Novel RNA construct increases cytotoxic proteins in lymphocytes and leads to prolonged survival in an experimental syngeneic immunocompetent Multiple Myeloma model (2019) (0)
- Reply to A. Gratwohl (2011) (0)
- Chromosomal aberrations in leukemic low-grade malignant B-cell lymphoproliferative neoplasias (1985) (0)
- MICROSPECTROPHOTOMETRICALLY QUANTITATED PERIODIC ACID-SCHIFF REACTION NORMAL HUMAN NEUTROPHIL LEUKOCYTES AS A REFERENCE SYSTEM FOR THE (2011) (0)
- Third International Congress of Histochemistry and Cytochemistry: August 18–22, 1968, New York, N.Y. (1968) (0)
- Efficacy and outcome of allogeneic transplantation in rare myeloma (2011) (0)
- Therapeutic Effects of Low-Dose Cytosine Arabinoside, α-Interferon, 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Myelodysplastic Syndromes and Acute Leukemia (1987) (0)
- INTRODUCTION (1987) (0)
- Leukocytes from Patients with Infectious Mononucleosis Structural Changes in the Deoxyribonucleoprotein (DNP) Complex of (2011) (0)
- DDH315 2925..2936 (2004) (0)
- Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma (2018) (0)
- CAR-T cell treatment of high-risk multiple myeloma - will there be a cure? (2023) (0)
- Intranuclear hemoglobin in erythroblasts of beta-thalassemia. (1974) (0)
- Characterisation of the minimal area of homozygous 13q14.3 deletion in B-CLL and isolation of candidate tumour suppressor genes. (1996) (0)
- lymphocytic leukemia and leukemic immunocytoma Prognostic information from cytogenetic analysis in chronic B (2011) (0)
- lymphocytic leukemia (letter; comment) Chromosome abnormalities and RB1 gene deletions in chronic (2011) (0)
- Management of Non-Hodgkin’s Lymphomas in Adults in Scandinavia, the United Kingdom and the Netherlands: Conclusions of the Fourth Intercity Meeting, 1988 (1990) (0)
- [Interferon prevention in transplantation]. (1979) (0)
- revealed by polyclonal B-cell-mitogen stimulation Nonrandom chromosomal aberrations in chronic lymphocytic leukemia (2011) (0)
- Response to Caravita di Toritto and Rago (2023) (0)
- Activation and differentiation in vitro of human lymphoma cells: a new method for the cytological evaluation of the lymphoma patient (1985) (0)
- [Bone marrow transplantation. A EEC-project with unrelated donors saves more and more people]. (1993) (0)
- [Immunotherapy of leukemia--a realistic clinical possibility?]. (1971) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gösta Gahrton?
Gösta Gahrton is affiliated with the following schools:
